Mrv1909 12091921222D 9 8 0 0 0 0 999 V2000 -2.5007 0.0784 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 0.4908 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 0.4908 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 -0.7466 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.0718 0.4908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7863 0.0784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 0.0784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5007 0.4908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 0.0784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 3 1 0 0 0 0 2 7 1 0 0 0 0 2 9 2 0 0 0 0 3 9 1 0 0 0 0 4 9 1 0 0 0 0 5 6 1 0 0 0 0 5 7 1 0 0 0 0 6 8 1 0 0 0 0 M END > DB02727 > drugbank > CCCC\N=C(/N)NO > InChI=1S/C5H13N3O/c1-2-3-4-7-5(6)8-9/h9H,2-4H2,1H3,(H3,6,7,8) > ULDDTFAPYWLDGF-UHFFFAOYSA-N > C5H13N3O > 131.1762 > 131.105862053 > 4 > 22 > 14.679948385656767 > 1 > 3 > 0 > 0 > (E)-N''-butyl-N-hydroxyguanidine > 0.25 > 0.37238767133333317 > -1.29 > 0 > 0 > 1 > 18.797419252704 > 14.819723336234357 > 10.24989224159934 > 70.64 > 46.4716 > 3 > 1 > 6.65e+00 g/l > [(1R,2S,6S,9R,11S)-11-(hydroxymethyl)-4,4,11-trimethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0^{2,6}]dodecan-6-yl]methyl sulfamate > 0 > DB02727 > EXPT00698 > experimental > 2-butyl-1-hydroxyguanidine > N-butyl-N'-hydroxyguanidine $$$$